{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:18:11Z","timestamp":1758845891340,"version":"3.44.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Dupilumab-associated head and neck dermatitis in patients with atopic dermatitis has been extensively documented. A distinctive short-lived facial erythema after alcohol ingestion in patients treated with dupilumab has recently emerged.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To characterize alcohol-induced facial erythema on treatment with dupilumab.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a systematic review based on PubMed and Google Scholar searches for publications on alcohol-induced facial erythema on treatment with dupilumab. A case series from our centre was added to this review. Data were summarized using descriptive statistics and a narrative review. This systematic review adhered to PRISMA reporting guidelines and was registered with PROSPERO (CRD42024571723).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Seven publications describing nine patients and five more from our case series were included. All were adults treated for atopic dermatitis (nine males; mean age 32.4\u2005years, SD 9.8). Six patients applied concomitant topical calcineurin inhibitors. At a median of 26 weeks (range 3 weeks to 3\u2005years) from dupilumab initiation, patients exhibited facial erythema\/flushing within minutes of alcohol consumption, resolving spontaneously in an hour. No patient discontinued dupilumab. One patient reported initial successful prophylaxis with a histamine H2-receptor antagonist.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Alcohol-induced facial erythema\/flushing on dupilumab has only been described in atopic dermatitis and is characterized by an acute onset and rapid resolution. Topical calcineurin inhibitor applications did not account for most patients\u2019 cases. Although seemingly an uncommon phenomenon, its social media presence suggests that it is underreported and troublesome to patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ced\/llaf206","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:20:28Z","timestamp":1747203628000},"page":"1975-1981","source":"Crossref","is-referenced-by-count":0,"title":["Alcohol-induced facial erythema in patients treated with dupilumab: a case series and systematic review"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2589-3039","authenticated-orcid":false,"given":"Amit","family":"Iton-Schwartz","sequence":"first","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center , Petah Tikva ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rivka","family":"Friedland","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology Unit, Schneider Children\u2019s Medical Center , Petah Tikva ,","place":["Israel"]},{"name":"Gray Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mimouni","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center , Petah Tikva ,","place":["Israel"]},{"name":"Gray Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8740-9674","authenticated-orcid":false,"given":"Yael A","family":"Leshem","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Rabin Medical Center , Petah Tikva ,","place":["Israel"]},{"name":"Gray Faculty of Medical and Health Sciences, Tel Aviv University , Tel Aviv ,","place":["Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"2025092509023767200_llaf206-B1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaad.2021.01.012","article-title":"Facial and neck erythema associated with dupilumab treatment: a systematic review","volume":"84","author":"Jo","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2025092509023767200_llaf206-B2","doi-asserted-by":"crossref","first-page":"e15140","DOI":"10.1111\/dth.15140","article-title":"Dupilumab facial redness: clinical characteristics and proposed treatment in a cohort","volume":"34","author":"Ord\u00f3\u00f1ez-Rubiano","year":"2021","journal-title":"Dermatol Ther"},{"key":"2025092509023767200_llaf206-B3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jamadermatol.2019.0109","article-title":"Assessment of the development of new regional dermatoses in patients treated for atopic dermatitis with dupilumab","volume":"155","author":"Zhu","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2025092509023767200_llaf206-B4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.12788\/cutis.0316","article-title":"Dupilumab-induced facial flushing after alcohol consumption","volume":"108","author":"Brownstone","year":"2021","journal-title":"Cutis"},{"key":"2025092509023767200_llaf206-B5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jdcr.2019.12.002","article-title":"Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab","volume":"6","author":"Igelman","year":"2020","journal-title":"JAAD Case Rep"},{"key":"2025092509023767200_llaf206-B6","doi-asserted-by":"crossref","first-page":"e12762","DOI":"10.1111\/dth.12762","article-title":"New alcohol flushing in a patient with atopic dermatitis under therapy with dupilumab","volume":"32","author":"Herz","year":"2019","journal-title":"Dermatol Ther"},{"key":"2025092509023767200_llaf206-B7","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.5021\/ad.21b.038","article-title":"New onset of alcohol flushing in an atopic dermatitis patient treated with dupilumab","volume":"35","author":"Choi","year":"2023","journal-title":"Ann Dermatol"},{"key":"2025092509023767200_llaf206-B8","doi-asserted-by":"crossref","first-page":"e15064","DOI":"10.1111\/dth.15064","article-title":"Alcohol flushing during dupilumab therapy: an emerging adverse event","volume":"34","author":"Napolitano","year":"2021","journal-title":"Dermatol Ther"},{"key":"2025092509023767200_llaf206-B9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/1346-8138.16764","article-title":"Dupilumab-associated cutaneous adverse events among adult patients with atopic dermatitis: a retrospective study","volume":"50","author":"Napolitano","year":"2023","journal-title":"J Dermatol"},{"key":"2025092509023767200_llaf206-B10","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.aller.2019.12.005","article-title":"Severe atopic dermatitis: dupilumab is not just safer, but more efficient","volume":"48","author":"Giavina-Bianchi","year":"2020","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2025092509023767200_llaf206-B11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025092509023767200_llaf206-B12","article-title":"Alcohol-induced facial erythema in patients treated with dupilumab: a case series and systematic review","author":"Iton","year":"2024","journal-title":"PROSPERO"},{"key":"2025092509023767200_llaf206-B13","doi-asserted-by":"crossref","first-page":"e0138237","DOI":"10.1371\/journal.pone.0138237","article-title":"The role of Google Scholar in evidence reviews and its applicability to grey literature searching","volume":"10","author":"Haddaway","year":"2015","journal-title":"PLOS ONE"},{"key":"2025092509023767200_llaf206-B14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an Umbrella review approach","volume":"13","author":"Aromataris","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"2025092509023767200_llaf206-B15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.15288\/jsa.1988.49.16","article-title":"Antihistamine blockade of alcohol-induced flushing in orientals","volume":"49","author":"Miller","year":"1988","journal-title":"J Stud Alcohol"},{"key":"2025092509023767200_llaf206-B16","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"2025092509023767200_llaf206-B17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40257-021-00646-z","article-title":"Dupilumab facial redness\/dupilumab facial dermatitis: a guide for clinicians","volume":"23","author":"Muzumdar","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"2025092509023767200_llaf206-B18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/15332640902897156","article-title":"Late life alcohol use and gender differences among Former Soviet Union immigrants","volume":"8","author":"Isralowitz","year":"2009","journal-title":"J Ethn Subst Abuse"},{"key":"2025092509023767200_llaf206-B19","doi-asserted-by":"crossref","first-page":"01","DOI":"10.35946\/arcr.v40.2.01","article-title":"Gender differences in the epidemiology of alcohol use and related harms in the United States","volume":"40","author":"White","year":"2020","journal-title":"Alcohol Res"},{"key":"2025092509023767200_llaf206-B20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/10550490590949578","article-title":"Israel 2000: immigration and gender differences in alcohol consumption","volume":"14","author":"Schiff","year":"2005","journal-title":"Am J Addict"},{"key":"2025092509023767200_llaf206-B21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13584-020-00410-4","article-title":"Differences in substance use by sexual orientation and gender among Jewish young adults in Israel","volume":"9","author":"Bonny-Noach","year":"2020","journal-title":"Isr J Health Policy Res"},{"author":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","key":"2025092509023767200_llaf206-B22"},{"key":"2025092509023767200_llaf206-B23","first-page":"258","article-title":"Role of acetaldehyde in mediating the pharmacological and behavioral effects of alcohol","volume":"29","author":"Quertemont","year":"2006","journal-title":"Alcohol Res Health"},{"key":"2025092509023767200_llaf206-B24","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pmed.1000050","article-title":"The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption","volume":"6","author":"Brooks","year":"2009","journal-title":"PLoS Med"},{"author":"DUPIXENT","key":"2025092509023767200_llaf206-B25"},{"key":"2025092509023767200_llaf206-B26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1517\/17425251003601979","article-title":"Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: a review","volume":"6","author":"Njoku","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2025092509023767200_llaf206-B27","first-page":"e46744","article-title":"Topical tacrolimus and alcohol-induced facial flushing: a case report and literature review","volume":"15","author":"Tekmen","year":"2023","journal-title":"Cureus"},{"key":"2025092509023767200_llaf206-B28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjd.17869","article-title":"Conjunctivitis in dupilumab clinical trials","volume":"181","author":"Akinlade","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025092509023767200_llaf206-B29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/cea.13954","article-title":"Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases","volume":"51","author":"Hamilton","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"2025092509023767200_llaf206-B30","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/s41467-024-46540-0","article-title":"Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells","volume":"15","author":"Bangert","year":"2024","journal-title":"Nat Commun"},{"key":"2025092509023767200_llaf206-B31","doi-asserted-by":"crossref","first-page":"e12221","DOI":"10.1002\/clt2.12221","article-title":"High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease","volume":"13","author":"Achten","year":"2023","journal-title":"Clin Transl Allergy"},{"key":"2025092509023767200_llaf206-B32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/bjd.17538","article-title":"Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis","volume":"180","author":"Bakker","year":"2019","journal-title":"Br J Dermatol"},{"key":"2025092509023767200_llaf206-B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00498250110035615","article-title":"Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole","volume":"31","author":"Furuta","year":"2001","journal-title":"Xenobiotica"},{"key":"2025092509023767200_llaf206-B34","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/sj.bjc.6600102","article-title":"Interaction of cimetidine with P450 in a mouse model of hepatocarcinogenesis initiation","volume":"86","author":"Caballero","year":"2002","journal-title":"Br J Cancer"},{"key":"2025092509023767200_llaf206-B35","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamadermatol.2019.3508","article-title":"Effect of topical brimonidine on alcohol-induced flushing in Asian individuals: a randomized clinical trial","volume":"156","author":"Yu","year":"2020","journal-title":"JAMA Dermatol"},{"author":"Reddit posts","key":"2025092509023767200_llaf206-B36"},{"author":"Pi\u00f1a","key":"2025092509023767200_llaf206-B37"},{"author":"Reddit posts","key":"2025092509023767200_llaf206-B38"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf206\/63175356\/llaf206.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/10\/1975\/63175356\/llaf206.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/10\/1975\/63175356\/llaf206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:02:50Z","timestamp":1758805370000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/10\/1975\/8130896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5,14]]},"published-print":{"date-parts":[[2025,9,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf206","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"type":"print","value":"0307-6938"},{"type":"electronic","value":"1365-2230"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,5,14]]}}}